{"id":102803,"date":"2014-01-23T14:51:38","date_gmt":"2014-01-23T19:51:38","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/2014-louis-jeantet-prize-for-medicine.php"},"modified":"2014-01-23T14:51:38","modified_gmt":"2014-01-23T19:51:38","slug":"2014-louis-jeantet-prize-for-medicine","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/2014-louis-jeantet-prize-for-medicine.php","title":{"rendered":"2014 Louis-Jeantet Prize for Medicine"},"content":{"rendered":"<p><p>    PUBLIC RELEASE DATE:  <\/p>\n<p>    21-Jan-2014  <\/p>\n<p>    Contact: Carole Liernur    <a href=\"mailto:liernur@jeantet.ch\">liernur@jeantet.ch<\/a>    41-227-043-631    European Molecular Biology    Organization<\/p>\n<p>    The 2014 LOUIS-JEANTET PRIZE FOR MEDICINE is awarded to the    Italian biochemist Elena Conti, Director of the Department of    Structural Cell Biology at the Max-Planck Institute of    Biochemistry in Munich (Germany) and to Denis Le Bihan, the    French medical doctor, physicist and Director of NeuroSpin, an    institute at the French Nuclear and Renewable Energy Commission    (CEA) at Saclay near Paris.  <\/p>\n<p>    The LOUIS-JEANTET FOUNDATION grants the sum of CHF 700'000 for    each of the two 2014 prizes, of which CHF 625'000 is for the    continuation of the prize-winner's work and CHF 75'000 for    their personal use.  <\/p>\n<p>    THE PRIZE-WINNERS are conducting fundamental biological    research which is expected to be of considerable significance    for medicine.  <\/p>\n<p>    ELENA CONTI is awarded the 2014 Louis-Jeantet Prize for    Medicine for her important contributions to understanding the    mechanisms governing ribonucleic acid (RNA) quality, transport    and degradation.  <\/p>\n<p>    In order to function properly, our cells need to degrade    macromolecules that are faulty or no longer needed. The    biochemist deciphered at the level of atomic resolution how    faulty RNAs are recognized and eliminated. Notably, her group    deciphered the three-dimensional architecture and molecular    mechanisms of the exosome, a multiprotein complex that    recognizes and degrades RNAs. The work revealed that several    principles of the mechanism of this essential nano-machine are    conserved in different forms of life.  <\/p>\n<p>    Elena Conti will use the prize money to conduct further    research into the structure and regulation of the exosome.  <\/p>\n<p>    DENIS LE BIHAN is awarded the 2014 Louis-Jeantet Prize for    Medicine for the development of a new imaging method that has    revolutionized the diagnosis and treatment of strokes.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Link:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2014-01\/embo-2lp012114.php\" title=\"2014 Louis-Jeantet Prize for Medicine\">2014 Louis-Jeantet Prize for Medicine<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PUBLIC RELEASE DATE: 21-Jan-2014 Contact: Carole Liernur <a href=\"mailto:liernur@jeantet.ch\">liernur@jeantet.ch<\/a> 41-227-043-631 European Molecular Biology Organization The 2014 LOUIS-JEANTET PRIZE FOR MEDICINE is awarded to the Italian biochemist Elena Conti, Director of the Department of Structural Cell Biology at the Max-Planck Institute of Biochemistry in Munich (Germany) and to Denis Le Bihan, the French medical doctor, physicist and Director of NeuroSpin, an institute at the French Nuclear and Renewable Energy Commission (CEA) at Saclay near Paris. The LOUIS-JEANTET FOUNDATION grants the sum of CHF 700'000 for each of the two 2014 prizes, of which CHF 625'000 is for the continuation of the prize-winner's work and CHF 75'000 for their personal use <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/2014-louis-jeantet-prize-for-medicine.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-102803","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/102803"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=102803"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/102803\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=102803"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=102803"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=102803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}